# DTA (Dopaminergic Therapy for Anhedonia) Study

> **NCT04723147** · PHASE4 · COMPLETED · sponsor: **Emory University** · enrollment: 19 (actual)

## Conditions studied

- Depression
- Anhedonia

## Interventions

- **DRUG:** Carbidopa Levodopa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04723147
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-29
- **Primary completion:** 2023-10-11
- **Final completion:** 2023-10-11
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2024-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04723147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04723147, "DTA (Dopaminergic Therapy for Anhedonia) Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04723147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*